- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 33/242 - Gold; Compounds thereof
Patent holdings for IPC class A61K 33/242
Total number of patents in this class: 247
10-year publication summary
1
|
1
|
3
|
10
|
17
|
42
|
59
|
56
|
42
|
14
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shenzhen Profound View Pharmaceutical Technology Co., Ltd. | 17 |
12 |
Nanobiotix | 103 |
6 |
Northwestern University | 3112 |
5 |
Medsenic | 8 |
5 |
Galera Labs, LLC | 55 |
4 |
Shenzhen Profound-View Pharma Tech Co., Ltd | 12 |
4 |
The Regents of the University of California | 18943 |
3 |
Board of Regents, The University of Texas System | 5370 |
3 |
The General Hospital Corporation | 4517 |
3 |
Case Western Reserve University | 1727 |
3 |
Clene Nanomedicine, Inc. | 32 |
3 |
University of Kentucky Research Foundation | 643 |
3 |
Varian Medical Systems, Inc. | 850 |
3 |
Seoul National University R&db Foundation | 2976 |
3 |
Wuhan Vast Conduct Science Foundation Co., Ltd. | 13 |
3 |
Uppsala Therapeutics AB | 3 |
3 |
Sardeshmukh, Sadanand Prabhakar | 6 |
3 |
The Bioregentech Institute, Inc. | 14 |
3 |
Duke University | 2872 |
2 |
University of South Florida | 1817 |
2 |
Other owners | 171 |